OncoRes Medical: Funding, Investors & Team (Sep 2026)
OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to assist with the identification of tumor and healthy tissue. OncoRes Medical is an early-stage medical device company located in Perth, Western Australia and is developing the patent-protected technology in collaboration with leading researchers at the University of Western Australia and the Harry Perkins Institute of Medical Research and breast cancer surgeons at the Western Australian public health system. With funding provided by the Medical Research Commercialisation Fund (MRCF), OncoRes Medical aims to develop the technology for use in clinical applications that require the real-time assessment of tissue microstructure.
OncoRes Medical has raised $25.8M across 2 funding rounds on record, the most recent an undisclosed round of $19.2M announced in Feb 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
OncoRes Medical Company Profile and Key Stats
Latest funding round on record: Feb 2026.
OncoRes Medical Funding Rounds
OncoRes Medical raised $6.6M in a Series A announced in May 2022.
3.8 years later, an undisclosed round of $19.2M was announced in Feb 2026.
OncoRes Medical Founders and Leadership Team
Contact details for the OncoRes Medical team: 1 of 1 has an email address on file.
Start 14-day free trial →OncoRes Medical Funding Compared to Other Biotechnology Startups
OncoRes Medical's latest round of $19.2M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like OncoRes Medical in Biotechnology and Nedlands
Companies Similar to OncoRes Medical
AdvanCell is a company that focuses on developing innovative cancer treatments using alpha-emitting isotopes…
The objective of Fluent is to seamlessly integrate humans with AI, improving interaction and communication…
Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's…
Microba Life Sciences Ltd. provides consumers, doctors, and researchers with gut microbiome testing services…
Algenie was founded on a simple realization: algae has the potential to save the earth, but only if it is…
Paradigm Pharmaceuticals is a global biopharmaceutical company driven to discover, develop, and deliver…
Imugene is a publicly-listed biotechnology company with operations in America and Europe,
BiomeBank’s mission is to treat and prevent disease by restoring gut microbial ecology
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing…
Cauldron Ferm is a technique that speeds up the production of precision fermented prototypes to commercial…
HydGene Renewables is developing a biotechnology platform that produces on-site green hydrogen from waste…
Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more…
OncoRes Medical Funding FAQs
What does OncoRes Medical do?
OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to assist with the identification of tumor and healthy tissue. OncoRes Medical is an early-stage medical device company located in Perth, Western Australia and is developing the patent-protected technology in collaboration with leading researchers at the University of Western Australia and the Harry Perkins Institute of Medical Research and breast cancer surgeons at the Western Australian public health system. With funding provided by the Medical Research Commercialisation Fund (MRCF), OncoRes Medical aims to develop the technology for use in clinical applications that require the real-time assessment of tissue microstructure.
How much funding has OncoRes Medical raised?
OncoRes Medical has raised $25.8M across 2 rounds on record. The most recent is an undisclosed round of $19.2M announced in Feb 2026.
When did OncoRes Medical last raise funding?
OncoRes Medical's most recent funding round on record is an undisclosed round of $19.2M, announced in Feb 2026.
Who is the CEO of OncoRes Medical?
Katharine Giles is listed as CEO at OncoRes Medical.
Where is OncoRes Medical headquartered?
OncoRes Medical is based in Nedlands, Western Australia, Australia.
How many employees does OncoRes Medical have?
OncoRes Medical is in the 11-50 employee band.
How does OncoRes Medical's funding compare to other Biotechnology startups?
OncoRes Medical's latest round of $19.2M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's OncoRes Medical Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for OncoRes Medical is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.